Results 31 to 40 of about 2,965 (169)

Tofacitinib for Prurigo Nodularis: A Case Report

open access: yesClinical, Cosmetic and Investigational Dermatology, 2022
Changlan Peng,1 Chunxiao Li,2 Yingying Zhou,1 Qiuyue Wang,1 Ping Xie,1 Tianhao Li,2,* Pingsheng Hao2,* 1Department of Dermatology, Chengdu University of Traditional Chinese Medicine, Chengdu, People’s Republic of China; 2Department of Dermatology,
Peng C   +6 more
doaj  

Effectiveness of upadacitinib in Japanese patients with prurigo‐type atopic dermatitis: Four cases report

open access: yesJournal of Cutaneous Immunology and Allergy, 2023
We present four Japanese patients with prurigo‐type AD who received upadacitinib. Rapid improvement of skin lesions and itchiness was seen in all patients. Janus kinase inhibitor is effective for prurigo‐type AD by strongly suppressing itching.
Keiji Kosaka   +3 more
doaj   +1 more source

Successful Treatment of Recalcitrant Prurigo with Alitretinoin [PDF]

open access: yes, 2015
BACKGROUND Chronic itch with secondary scratch lesions such as prurigo has a major impact on quality of life. Due to its relapsing nature and often unknown origin, its treatment is challenging.
Gadaldi, Karolina   +5 more
core   +3 more sources

Startups Driving Artificial Intelligence Into Clinical Dermatology

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Artificial intelligence (AI) is rapidly transitioning from innovation to routine clinical application in dermatology. This review examines how AI‐enabled technologies are being developed and integrated across diverse clinical purposes and workflows.
Dominique Du Crest   +10 more
wiley   +1 more source

Prurigo pigmentoso

open access: yesActas Dermo-Sifiliográficas, 2005
Prurigo pigmentosa is an infrequent inflammatory dermatosis of unknown etiology, characterized by recurrent episodes of pruritic erythematous papules which develop into intense reticulated pigmentation. It has been referenced most frequently in young women in Japan. Only thirty cases have been described outside of Japan.
Eloy, Rodríguez-Díaz   +5 more
openaire   +2 more sources

Out‐of‐pocket expenditures in adult patients with prurigo nodularis in France

open access: yesJEADV Clinical Practice, 2023
Background Chronic prurigo or prurigo nodularis is a severe condition with chronic pruritus and skin lesions. Current unnmet medical needs are numerous and generate a significant burden for the patients.
Laurent Misery   +6 more
doaj   +1 more source

Circulating plasma IL-13 and periostin are dysregulated type 2 inflammatory biomarkers in prurigo nodularis: A cluster analysis

open access: yesFrontiers in Medicine, 2022
ImportancePrurigo nodularis (PN) is a chronic heterogeneous inflammatory skin disease.ObjectiveTo elucidate which components of type 2 inflammation are dysregulated systemically in PN.DesignWhole blood was obtained from PN patients with uncontrolled ...
Varsha Parthasarathy   +10 more
doaj   +1 more source

Atopic dermatitis and attention‐deficit/hyperactivity disorder comorbidity in children and adolescents: Epidemiology, mechanisms, and clinical management

open access: yesPediatric Investigation, EarlyView.
This review synthesizes epidemiological evidence linking atopic dermatitis to attention‐deficit/hyperactivity disorder in children, proposes an “inflammation‐itch‐neurobehavioral axis” integrating sleep disruption, neuroendocrine dysregulation, and emerging neuro‐immune circuits, and outlines multidisciplinary management strategies targeting both skin ...
Qingyang Zhao   +11 more
wiley   +1 more source

The Origins of Allergy: An Outside‐In, Bioenergetic Hypothesis

open access: yesAllergy, EarlyView.
ABSTRACT Allergic disease has risen too rapidly for inherited susceptibility to explain it, and the risk variants so far reported lie in the epithelial barrier and in type‐2 immunity. We propose a five‐layer model in which epithelial barrier and bioenergetic dysfunction may precede and promote type‐2 immune deviation rather than arise solely as its ...
Peter K. Smith   +9 more
wiley   +1 more source

PRURIGO COMO MARCADOR CUTÂNEO DE INFECÇÃO PELO HTLV

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2014
Introdução: O prurigo ainda não foi definitivamente associado à infecção pelo HTLV. Entretanto, há relatos de casos com aparecimento dessas lesões anos antes de surgimento de Leucemia Linfoma de Células T do Adulto(LLTA), como pródromo da neoplasia ...
Tiago Silveira-Lima   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy